INTerpath-007
Phase 2/3 Completed
46 enrolled
TRIPLET
Phase 2/3 Completed
229 enrolled
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Phase 2/3 Completed
159 enrolled 17 charts
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer
Phase 2/3 Completed
418 enrolled 52 charts
Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
Phase 2/3 Completed
400 enrolled 15 charts
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Phase 2/3 Completed
119 enrolled
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Phase 2/3 Completed
196 enrolled 31 charts
Intensified Chemotherapy in CRC After Resection of Liver Metastases
Phase 2/3 Completed
124 enrolled
SKYSCRAPER-06
Phase 2/3 Completed
542 enrolled
Perioperative Intravenous Lidocaine in Liver Surgery
Phase 2/3 Completed
124 enrolled
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
Phase 2/3 Completed
612 enrolled
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
Phase 2/3 Completed
201 enrolled
Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection
Phase 2/3 Completed
150 enrolled
Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
Phase 2/3 Completed
57 enrolled 15 charts
KETAPAL
Phase 2/3 Completed
42 enrolled
Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial
Phase 2/3 Completed
74 enrolled
EXHITENTRE
Phase 2/3 Completed
344 enrolled
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
Phase 2/3 Completed
260 enrolled 20 charts
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
Phase 2/3 Completed
129 enrolled 23 charts
Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
Phase 2/3 Completed
52 enrolled
GuideView
Phase 2/3 Completed
195 enrolled 31 charts
SCRRYST
Phase 2/3 Completed
32 enrolled
POINT
Phase 2/3 Completed
19 enrolled
BM
Phase 2/3 Completed
492 enrolled
ADJUVITE
Phase 2/3 Completed
34 enrolled
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Phase 2/3 Completed
130 enrolled 8 charts
D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC
Phase 2/3 Completed
362 enrolled
PROBIOP
Phase 2/3 Completed
217 enrolled
Impact Of Metformin In Rectal Cancer Patients
Phase 2/3 Completed
85 enrolled
B-MIND
Phase 2/3 Completed
453 enrolled 29 charts
PROTECT-V
Phase 2/3 Completed
2,240 enrolled
Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial
Phase 2/3 Completed
504 enrolled
MAHOGANY
Phase 2/3 Completed
82 enrolled 22 charts
MIBI-THYR
Phase 2/3 Completed
372 enrolled
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
Phase 2/3 Completed
91 enrolled
Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
Phase 2/3 Completed
70 enrolled
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
Phase 2/3 Completed
399 enrolled 29 charts
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
Phase 2/3 Completed
6 enrolled 8 charts
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Phase 2/3 Completed
62 enrolled
ADAPT
Phase 2/3 Completed
4,936 enrolled
NICE
Phase 2/3 Completed
104 enrolled
ADAPT
Phase 2/3 Completed
4,936 enrolled
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Phase 2/3 Completed
10 enrolled
Erector Spinae Plane Block Versus Caudal Epidural Analgesia
Phase 2/3 Completed
32 enrolled
WT1 for the Detection of Minimal Residual Disease
Phase 2/3 Completed
50 enrolled
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2/3 Completed
10 enrolled 11 charts
NIVEAU
Phase 2/3 Completed
348 enrolled
MOUNTAINEER-02
Phase 2/3 Completed
17 enrolled 23 charts
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Phase 2/3 Completed
76 enrolled 16 charts
Chiglitazar/Metformin in Non-obese Women With PCOS
Phase 2/3 Completed
55 enrolled